GSK sets up vaccine manufacturing facility in India
The world leader in vaccines Glaxo Smithkline has set up a state-of-the-art vaccines facility conforming to international current Good Manufacturing Practices at Nashik in Maharashtra.

Cancer Genetics makes India Asian hub
The US based biotech major Cancer Genetics Inc founded by Indian American Dr Raju S K Chaganti, has introduced its 140 plus genetic probes product range through Genetics Specialties Pvt Ltd which would market its products in India exclusively.

Orchid inks pact with Alpharma to market oral non-antibiotic formulations in US & Europe
The Chennai-based Orchid Chemicals & Pharmaceuticals Ltd has entered into an exclusive agreement with Alpharma Inc for marketing its selected non-antibiotic generic formulations in US and Europe.

Budget a damp squib, quips industry
The Union Budget 2005-06 has failed to trigger much enthusiasm among the pharmaceutical industry. Industry expressed disappointment on the incentives announced by finance minister at both the R&D and manufacturing level.

J B Chemicals mfg facility at Panoli gets TGA Australia approval
J B Chemicals & Pharmaceuticals Ltd (JBCPL) has received approval from Therapeutic Goods Administration (TGA) - Australia for its tablets manufacturing facility at Panoli, Gujarat India.

Ranbaxy gets tentative approval to market donepezil hydrochloride tablets
Ranbaxy Laboratories Limited (RLL) announced that the company has received tentative approval from the US Food and Drug Administration (FDA) to manufacture and market donepezil hydrochloride tablets 5 mg and 10 mg.